Who’s Who with Optiscan: The next leap in real-time medical imaging

Optiscan (ASX:OIL) is redefining real-time diagnostics with its breakthrough confocal endomicroscopy technology.

This latest epsiode of Who’s Who, host Tylah Tully unpacks the Melbourne-based Optiscan, which is the only company delivering sub-cellular, in vivo imaging at the point of care giving surgeons, clinicians, and pathologists instant microscopic clarity without the delays of traditional pathology.

Backed by a powerhouse leadership team and collaborations with world-leading institutions like the Mayo Clinic and Zeiss Meditec, Optiscan’s patented tech is already transforming cancer detection, surgical precision, and veterinary care.

With products spanning billion-dollar markets, including InVue, InForm, and InSpecta,  the company is now advancing towards FDA submissions and commercial rollout.

This video was developed in collaboration with Optiscan, a Stockhead client at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.